RECURRENT CUTANEOUS MELANOMA
Clinical trials for RECURRENT CUTANEOUS MELANOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT CUTANEOUS MELANOMA trials appear
Sign up with your email to follow new studies for RECURRENT CUTANEOUS MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug combo tested to shrink tumors before melanoma surgery
Disease control TerminatedThis study tested whether giving two targeted drugs (encorafenib and binimetinib) before surgery could help shrink melanoma tumors in patients whose cancer had spread to nearby lymph nodes. The drugs aim to block signals that help cancer cells grow. The trial also tested whether …
Matched conditions: RECURRENT CUTANEOUS MELANOMA
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New immune cell therapy tested for kids with tough cancers
Disease control TerminatedThis early-stage study tested a new treatment for children and young adults whose solid tumors had returned or stopped responding to standard therapies. Researchers gave patients a combination of chemotherapy drugs followed by immune cells (NK cells) donated from umbilical cord b…
Matched conditions: RECURRENT CUTANEOUS MELANOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC